Availability of Injectable Antimicrobial Drugs for Gonorrhea and Syphilis, United States, 2016
Authors:
- William S. PearsonWPWilliam S. Pearson
- Donald K. CherryDCDonald K. Cherry
- Jami S. LeichliterJLJami S. Leichliter
- Laura H. BachmannLBLaura H. Bachmann
- Nicole A. CummingsNCNicole A. Cummings
- Matthew HogbenMHMatthew Hogben
Open Access
- 1 November 2019
- journal article
- letter
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 25 (11) , 2154-2156
Abstract
We estimated the availability of the injectable antimicrobial drugs recommended for point-of-care treatment of gonorrhea and syphilis among US physicians who evaluated patients with sexually transmitted infections in 2016. Most physicians did not have these drugs available on-site. Further research is needed to determine the reasons for the unavailability of these drugs.Keywords
This publication has 4 references indexed in Scilit:
- Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: An evaluation from multi-country surveys and stakeholder interviewsPLOS Medicine, 2017
- Patient-Centered Medical Home Adoption: Results From Aligning Forces For QualityHealth Affairs, 2016
- Sexually transmitted diseases treatment guidelines, 2015.2015
- Cephalosporin-Resistant Gonorrhea in North AmericaJAMA, 2013